Skip to main content
Erschienen in: Rheumatology International 1/2017

23.04.2016 | Review Therapy

An overview of treatment approaches for chronic pain management

verfasst von: Nicholas Hylands-White, Rui V. Duarte, Jon H. Raphael

Erschienen in: Rheumatology International | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Pain which persists after healing is expected to have taken place, or which exists in the absence of tissue damage, is termed chronic pain. By definition chronic pain cannot be treated and cured in the conventional biomedical sense; rather, the patient who is suffering from the pain must be given the tools with which their long-term pain can be managed to an acceptable level. This article will provide an overview of treatment approaches available for the management of persistent non-malignant pain. As well as attempting to provide relief from the physical aspects of pain through the judicious use of analgesics, interventions, stimulations, and irritations, it is important to pay equal attention to the psychosocial complaints which almost always accompany long-term pain. The pain clinic offers a biopsychosocial approach to treatment with the multidisciplinary pain management programme; encouraging patients to take control of their pain problem and lead a fulfilling life in spite of the pain.
Literatur
1.
Zurück zum Zitat Turk D, Melzack R (2011) The measurement of pain and the assessment of people experiencing pain. In: Turk D, Melzack R (eds) Handbook of pain assessment, 3rd edn. Guilford Press, New York, p 542 Turk D, Melzack R (2011) The measurement of pain and the assessment of people experiencing pain. In: Turk D, Melzack R (eds) Handbook of pain assessment, 3rd edn. Guilford Press, New York, p 542
3.
Zurück zum Zitat Melzack R, Wall PD (1996) The challenge of pain, 2nd edn. Penguin, London Melzack R, Wall PD (1996) The challenge of pain, 2nd edn. Penguin, London
5.
Zurück zum Zitat Engel G (1977) The need for a new medical model: a challenge for biomedicine. Science 196:129–136PubMedCrossRef Engel G (1977) The need for a new medical model: a challenge for biomedicine. Science 196:129–136PubMedCrossRef
6.
Zurück zum Zitat Jacobson L, Mariano A (2001) General considerations of chronic pain. In: Loeser J (ed) Bonica’s management of pain, 3rd edn. Lippincott, Williams & Wilkins, Philadelphia, pp 241–254 Jacobson L, Mariano A (2001) General considerations of chronic pain. In: Loeser J (ed) Bonica’s management of pain, 3rd edn. Lippincott, Williams & Wilkins, Philadelphia, pp 241–254
7.
Zurück zum Zitat Loeser J (1991) The role of chronic pain clinics in managing back pain. In: Frymoyer J (ed) Adult spine Princ. Pract. Raven Press, New York, pp 221–229 Loeser J (1991) The role of chronic pain clinics in managing back pain. In: Frymoyer J (ed) Adult spine Princ. Pract. Raven Press, New York, pp 221–229
9.
Zurück zum Zitat Ventafridda V, Saita L, Ripamonti C, De Conno F (1985) WHO guidelines for the use of analgesics in cancer pain. Int J Tissue React 7:93–96PubMed Ventafridda V, Saita L, Ripamonti C, De Conno F (1985) WHO guidelines for the use of analgesics in cancer pain. Int J Tissue React 7:93–96PubMed
12.
Zurück zum Zitat Rang H, Dale M, Ritter J, Flower R, Henderson G (2012) Rang & Dale’s Pharmacology, 7th edn. Elsevier, London Rang H, Dale M, Ritter J, Flower R, Henderson G (2012) Rang & Dale’s Pharmacology, 7th edn. Elsevier, London
14.
Zurück zum Zitat Silverstein F, Faich G, Goldstein J (2000) Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized. JAMA 284:1247–1255PubMedCrossRef Silverstein F, Faich G, Goldstein J (2000) Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized. JAMA 284:1247–1255PubMedCrossRef
15.
Zurück zum Zitat Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, Day R, Ferraz MB, Hawkey CJ, Hochberg MC, Kvien TK (2000) Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 343:1520–1528PubMedCrossRef Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, Day R, Ferraz MB, Hawkey CJ, Hochberg MC, Kvien TK (2000) Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 343:1520–1528PubMedCrossRef
16.
Zurück zum Zitat Schnitzer TJ, Burmester GR, Mysler E, Hochberg MC, Doherty M, Ehrsam E, Gitton X, Krammer G, Mellein B, Matchaba P, Gimona A, Hawkey CJ (2004) Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial. Lancet 364:665–674. doi:10.1016/S0140-6736(04)16893-1 PubMedCrossRef Schnitzer TJ, Burmester GR, Mysler E, Hochberg MC, Doherty M, Ehrsam E, Gitton X, Krammer G, Mellein B, Matchaba P, Gimona A, Hawkey CJ (2004) Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial. Lancet 364:665–674. doi:10.​1016/​S0140-6736(04)16893-1 PubMedCrossRef
17.
Zurück zum Zitat Solomon SD, McMurray JJV, Pfeffer MA, Wittes J, Fowler R, Finn P, Anderson WF, Zauber A, Hawk E, Bertagnolli M (2005) Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med 352:1071–1080. doi:10.1056/NEJMoa050405 PubMedCrossRef Solomon SD, McMurray JJV, Pfeffer MA, Wittes J, Fowler R, Finn P, Anderson WF, Zauber A, Hawk E, Bertagnolli M (2005) Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med 352:1071–1080. doi:10.​1056/​NEJMoa050405 PubMedCrossRef
18.
Zurück zum Zitat Bresalier RS, Sandler RS, Quan H, Bolognese JA, Oxenius B, Horgan K, Lines C, Riddell R, Morton D, Lanas A, Konstam MA, Baron JA (2005) Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 352:1092–1102. doi:10.1056/NEJMoa050493 PubMedCrossRef Bresalier RS, Sandler RS, Quan H, Bolognese JA, Oxenius B, Horgan K, Lines C, Riddell R, Morton D, Lanas A, Konstam MA, Baron JA (2005) Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 352:1092–1102. doi:10.​1056/​NEJMoa050493 PubMedCrossRef
20.
Zurück zum Zitat Nussmeier NA, Whelton AA, Brown MT, Langford RM, Hoeft A, Parlow JL, Boyce SW, Verburg KM (2005) Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery. N Engl J Med 352:1081–1091. doi:10.1056/NEJMoa050330 PubMedCrossRef Nussmeier NA, Whelton AA, Brown MT, Langford RM, Hoeft A, Parlow JL, Boyce SW, Verburg KM (2005) Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery. N Engl J Med 352:1081–1091. doi:10.​1056/​NEJMoa050330 PubMedCrossRef
21.
Zurück zum Zitat Kerr DJ, Dunn JA, Langman MJ, Smith JL, Midgley RSJ, Stanley A, Stokes JC, Julier P, Iveson C, Duvvuri R, McConkey CC (2007) Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer. N Engl J Med 357:360–369. doi:10.1056/NEJMoa071841 PubMedCrossRef Kerr DJ, Dunn JA, Langman MJ, Smith JL, Midgley RSJ, Stanley A, Stokes JC, Julier P, Iveson C, Duvvuri R, McConkey CC (2007) Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer. N Engl J Med 357:360–369. doi:10.​1056/​NEJMoa071841 PubMedCrossRef
22.
Zurück zum Zitat Cullen L, Kelly L, Connor SO, Fitzgerald DJ (1998) Selective cyclooxygenase-2 inhibition by nimesulide in man. J Pharmacol Exp Ther 287:578–582PubMed Cullen L, Kelly L, Connor SO, Fitzgerald DJ (1998) Selective cyclooxygenase-2 inhibition by nimesulide in man. J Pharmacol Exp Ther 287:578–582PubMed
25.
Zurück zum Zitat Capone ML, Tacconelli S, Sciulli MG, Grana M, Ricciotti E, Minuz P, Di Gregorio P, Merciaro G, Patrono C, Patrignani P (2004) Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects. Circulation 109:1468–1471. doi:10.1161/01.CIR.0000124715.27937.78 PubMedCrossRef Capone ML, Tacconelli S, Sciulli MG, Grana M, Ricciotti E, Minuz P, Di Gregorio P, Merciaro G, Patrono C, Patrignani P (2004) Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects. Circulation 109:1468–1471. doi:10.​1161/​01.​CIR.​0000124715.​27937.​78 PubMedCrossRef
26.
Zurück zum Zitat Hecken A, Schwartz JI, Depré M, Lepeleire I, Dallob A, Tanaka W, Wynants K, Buntinx A, Arnout J, Wong PH, Ebel DL (2000) Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX2 versus COX1 in healthy volunteers. J Clin Pharmacol 40:1109–1120PubMed Hecken A, Schwartz JI, Depré M, Lepeleire I, Dallob A, Tanaka W, Wynants K, Buntinx A, Arnout J, Wong PH, Ebel DL (2000) Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX2 versus COX1 in healthy volunteers. J Clin Pharmacol 40:1109–1120PubMed
27.
29.
Zurück zum Zitat Ray WA, Varas-Lorenzo C, Chung CP, Castellsague J, Murray KT, Stein CM, Daugherty JR, Arbogast PG, García-Rodríguez LA (2009) Cardiovascular risks of nonsteroidal antiinflammatory drugs in patients after hospitalization for serious coronary heart disease. Circ Cardiovasc Qual Outcomes 2:155–163. doi:10.1161/CIRCOUTCOMES.108.805689 PubMedCrossRef Ray WA, Varas-Lorenzo C, Chung CP, Castellsague J, Murray KT, Stein CM, Daugherty JR, Arbogast PG, García-Rodríguez LA (2009) Cardiovascular risks of nonsteroidal antiinflammatory drugs in patients after hospitalization for serious coronary heart disease. Circ Cardiovasc Qual Outcomes 2:155–163. doi:10.​1161/​CIRCOUTCOMES.​108.​805689 PubMedCrossRef
30.
Zurück zum Zitat Bhala N, Emberson J, Merhi A, Abramson S, Arber N, Baron JA, Bombardier C, Cannon C, Farkouh ME, FitzGerald GA, Goss P, Halls H, Hawk E, Hawkey C, Hennekens C, Hochberg M, Holland LE, Kearney PM, Laine L, Lanas A, Lance P, Laupacis A, Oates J, Patrono C, Schnitzer TJ, Solomon S, Tugwell P, Wilson K, Wittes J, Baigent C (2013) Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet (London, England) 382:769–79. doi:10.1016/S0140-6736(13)60900-9 Bhala N, Emberson J, Merhi A, Abramson S, Arber N, Baron JA, Bombardier C, Cannon C, Farkouh ME, FitzGerald GA, Goss P, Halls H, Hawk E, Hawkey C, Hennekens C, Hochberg M, Holland LE, Kearney PM, Laine L, Lanas A, Lance P, Laupacis A, Oates J, Patrono C, Schnitzer TJ, Solomon S, Tugwell P, Wilson K, Wittes J, Baigent C (2013) Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet (London, England) 382:769–79. doi:10.​1016/​S0140-6736(13)60900-9
35.
Zurück zum Zitat Trescot AM, Helm S, Hansen H, Benyamin R, Glaser SE, Adlaka R, Patel S (2008) Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians’ (ASIPP) Guidelines. Pain Phys 11:S5–S62 Trescot AM, Helm S, Hansen H, Benyamin R, Glaser SE, Adlaka R, Patel S (2008) Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians’ (ASIPP) Guidelines. Pain Phys 11:S5–S62
38.
Zurück zum Zitat Goldenberg DL, Burckhardt C, Crofford L (2014) Manag Fibromyalgia Syndr 292:2388–2395 Goldenberg DL, Burckhardt C, Crofford L (2014) Manag Fibromyalgia Syndr 292:2388–2395
41.
Zurück zum Zitat Fitzcharles M, Ste-marie PA, Goldenberg DL, John X, Abbey S, Choinière M, Ko G, Moulin D, Panopalis P, Proulx J, Shir Y (2012) 2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome. Pain Res Manag 18:1–52 Fitzcharles M, Ste-marie PA, Goldenberg DL, John X, Abbey S, Choinière M, Ko G, Moulin D, Panopalis P, Proulx J, Shir Y (2012) 2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome. Pain Res Manag 18:1–52
44.
Zurück zum Zitat Pergolizzi J, Aloisi AM, Dahan A, Filitz J, Langford R, Likar R, Mercadante S, Morlion B, Raffa RB, Sabatowski R, Sacerdote P, Torres LM, Weinbroum AA (2010) Current Knowledge of Buprenorphine and Its Unique Pharmacological Profile. Pain Pract 10:428–450. doi:10.1111/j.1533-2500.2010.00378.x PubMedCrossRef Pergolizzi J, Aloisi AM, Dahan A, Filitz J, Langford R, Likar R, Mercadante S, Morlion B, Raffa RB, Sabatowski R, Sacerdote P, Torres LM, Weinbroum AA (2010) Current Knowledge of Buprenorphine and Its Unique Pharmacological Profile. Pain Pract 10:428–450. doi:10.​1111/​j.​1533-2500.​2010.​00378.​x PubMedCrossRef
45.
Zurück zum Zitat Dworkin RH, O’Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, Kalso EA, Loeser JD, Miaskowski C, Nurmikko TJ, Portenoy RK, Rice ASC, Stacey BR, Treede R-D, Turk DC, Wallace MS (2007) Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 132:237–251. doi:10.1016/j.pain.2007.08.033 PubMedCrossRef Dworkin RH, O’Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, Kalso EA, Loeser JD, Miaskowski C, Nurmikko TJ, Portenoy RK, Rice ASC, Stacey BR, Treede R-D, Turk DC, Wallace MS (2007) Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 132:237–251. doi:10.​1016/​j.​pain.​2007.​08.​033 PubMedCrossRef
46.
Zurück zum Zitat Campbell BJ, Rowbotham M, Davies PS, Jacob P, Benowitz NL (2002) Systemic absorption of topical lidocaine in normal volunteers, patients with post-herpetic neuralgia, and patients with acute herpes zoster. J Pharm Sci 91:1343–1350. doi:10.1002/jps.10133 PubMedCrossRef Campbell BJ, Rowbotham M, Davies PS, Jacob P, Benowitz NL (2002) Systemic absorption of topical lidocaine in normal volunteers, patients with post-herpetic neuralgia, and patients with acute herpes zoster. J Pharm Sci 91:1343–1350. doi:10.​1002/​jps.​10133 PubMedCrossRef
47.
Zurück zum Zitat Derry S, Wiffen P, Moore R, Quinlan J (2014) Topical lidocaine for neuropathic pain in adults (Review). Cochrane Database Syst Rev 7:1–50 Derry S, Wiffen P, Moore R, Quinlan J (2014) Topical lidocaine for neuropathic pain in adults (Review). Cochrane Database Syst Rev 7:1–50
49.
Zurück zum Zitat Arnold LM, Keck PEJ, Welge JA (2000) Antidepressant treatment of fibromyalgia. A meta-analysis and review. Psychosomatics 41:104–113PubMedCrossRef Arnold LM, Keck PEJ, Welge JA (2000) Antidepressant treatment of fibromyalgia. A meta-analysis and review. Psychosomatics 41:104–113PubMedCrossRef
51.
Zurück zum Zitat Watson CPN, Chipman ML, Monks RC (2006) Antidepressant analgesics: a systematic review and comparative study. In: McMahon S, Koltzenburg M (eds) Wall Melzack’s Textb. Pain, 5th edn. Elsevier, London, p 1280 Watson CPN, Chipman ML, Monks RC (2006) Antidepressant analgesics: a systematic review and comparative study. In: McMahon S, Koltzenburg M (eds) Wall Melzack’s Textb. Pain, 5th edn. Elsevier, London, p 1280
53.
Zurück zum Zitat Field MJ, Cox PJ, Stott E, Melrose H, Offord J, Su T-Z, Bramwell S, Corradini L, England S, Winks J, Kinloch RA, Hendrich J, Dolphin AC, Webb T, Williams D (2006) Identification of the alpha2-delta-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin. Proc Natl Acad Sci USA 103:17537–17542. doi:10.1073/pnas.0409066103 PubMedPubMedCentralCrossRef Field MJ, Cox PJ, Stott E, Melrose H, Offord J, Su T-Z, Bramwell S, Corradini L, England S, Winks J, Kinloch RA, Hendrich J, Dolphin AC, Webb T, Williams D (2006) Identification of the alpha2-delta-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin. Proc Natl Acad Sci USA 103:17537–17542. doi:10.​1073/​pnas.​0409066103 PubMedPubMedCentralCrossRef
54.
Zurück zum Zitat Crofford LJ, Mease PJ, Simpson SL, Young JP, Martin SA, Haig GM, Sharma U (2008) Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin. Pain 136:419–431. doi:10.1016/j.pain.2008.02.027 PubMedCrossRef Crofford LJ, Mease PJ, Simpson SL, Young JP, Martin SA, Haig GM, Sharma U (2008) Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin. Pain 136:419–431. doi:10.​1016/​j.​pain.​2008.​02.​027 PubMedCrossRef
55.
Zurück zum Zitat Vargas-Schaffer G (2010) Is the WHO analgesic ladder still valid? Twenty-four years of experience. Can Fam Physician 56(514–7):e202–e205PubMedCentral Vargas-Schaffer G (2010) Is the WHO analgesic ladder still valid? Twenty-four years of experience. Can Fam Physician 56(514–7):e202–e205PubMedCentral
56.
Zurück zum Zitat Pergolizzi BJV, Raffa RB (2014) The WHO pain ladder: do we need another step? Pract Pain Manag 14:1–17 Pergolizzi BJV, Raffa RB (2014) The WHO pain ladder: do we need another step? Pract Pain Manag 14:1–17
57.
Zurück zum Zitat Watts RW, Silagy CA (1995) A meta-analysis on the efficacy of epidural corticosteroids in the treatment of sciatica. Anaesth Intensive Care 23:564–569PubMed Watts RW, Silagy CA (1995) A meta-analysis on the efficacy of epidural corticosteroids in the treatment of sciatica. Anaesth Intensive Care 23:564–569PubMed
58.
Zurück zum Zitat McQuay H, Moore R (1998) Epidural corticosteroids for sciatica. In: An evidence-based Resour. Pain Reli. Oxford University Press, Oxford, p 270 McQuay H, Moore R (1998) Epidural corticosteroids for sciatica. In: An evidence-based Resour. Pain Reli. Oxford University Press, Oxford, p 270
59.
Zurück zum Zitat Boswell MV, Colson JD, Sehgal N, Dunbar EE, Epter R (2007) A systematic review of therapeutic facet joint interventions in chronic spinal pain. Pain Physician 10:229–253PubMed Boswell MV, Colson JD, Sehgal N, Dunbar EE, Epter R (2007) A systematic review of therapeutic facet joint interventions in chronic spinal pain. Pain Physician 10:229–253PubMed
61.
Zurück zum Zitat Geurts JW, van Wijk RM, Stolker RJ, Groen GJ (2001) Efficacy of radiofrequency procedures for the treatment of spinal pain: a systematic review of randomized clinical trials. Reg Anesth Pain Med 26:394–400. doi:10.1053/rapm.2001.23673 PubMed Geurts JW, van Wijk RM, Stolker RJ, Groen GJ (2001) Efficacy of radiofrequency procedures for the treatment of spinal pain: a systematic review of randomized clinical trials. Reg Anesth Pain Med 26:394–400. doi:10.​1053/​rapm.​2001.​23673 PubMed
62.
Zurück zum Zitat Schofferman J, Kine G (2004) Effectiveness of repeated radiofrequency neurotomy for lumbar facet pain. Spine (Phila Pa 1976) 29:2471–2473CrossRef Schofferman J, Kine G (2004) Effectiveness of repeated radiofrequency neurotomy for lumbar facet pain. Spine (Phila Pa 1976) 29:2471–2473CrossRef
63.
Zurück zum Zitat Onofrio B, Yaksh T, Arnold P (1981) Continuous low-dose intrathecal morphine administration in the treatment of chronic pain of malignant origin. Mayo Clin Proc 56:516–520PubMed Onofrio B, Yaksh T, Arnold P (1981) Continuous low-dose intrathecal morphine administration in the treatment of chronic pain of malignant origin. Mayo Clin Proc 56:516–520PubMed
64.
Zurück zum Zitat Levy R, Salzman D (1997) Implanted drug delivery systems for control of chronic pain. In: North R, Levy R (eds) Neurosurg. Manag. Pain. Springer, New York, pp 302–324CrossRef Levy R, Salzman D (1997) Implanted drug delivery systems for control of chronic pain. In: North R, Levy R (eds) Neurosurg. Manag. Pain. Springer, New York, pp 302–324CrossRef
65.
Zurück zum Zitat Prager J (2002) Neuraxial medication delivery: the development and maturity of a concept for treating chronic pain of spinal origin. Spine (Phila Pa 1976) 27:2593–2605CrossRef Prager J (2002) Neuraxial medication delivery: the development and maturity of a concept for treating chronic pain of spinal origin. Spine (Phila Pa 1976) 27:2593–2605CrossRef
66.
Zurück zum Zitat Raphael JH, Duarte RV, Southall JL, Nightingale P, Kitas GD (2013) Randomised, double-blind controlled trial by dose reduction of implanted intrathecal morphine delivery in chronic non-cancer pain. BMJ Open 3:e003061PubMedPubMedCentralCrossRef Raphael JH, Duarte RV, Southall JL, Nightingale P, Kitas GD (2013) Randomised, double-blind controlled trial by dose reduction of implanted intrathecal morphine delivery in chronic non-cancer pain. BMJ Open 3:e003061PubMedPubMedCentralCrossRef
70.
Zurück zum Zitat Cameron T (2004) Safety and efficacy of spinal cord stimulation for the treatment of chronic pain: a 20-year literature review. J Neurosurg 100:254–267PubMed Cameron T (2004) Safety and efficacy of spinal cord stimulation for the treatment of chronic pain: a 20-year literature review. J Neurosurg 100:254–267PubMed
71.
Zurück zum Zitat Kumar K, Taylor RS, Jacques L, Eldabe S, Meglio M, Molet J, Thomson S, O’Callaghan J, Eisenberg E, Milbouw G, Buchser E, Fortini G, Richardson J, North RB (2008) The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery 63:762–770. doi:10.1227/01.NEU.0000325731.46702.D9 PubMedCrossRef Kumar K, Taylor RS, Jacques L, Eldabe S, Meglio M, Molet J, Thomson S, O’Callaghan J, Eisenberg E, Milbouw G, Buchser E, Fortini G, Richardson J, North RB (2008) The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery 63:762–770. doi:10.​1227/​01.​NEU.​0000325731.​46702.​D9 PubMedCrossRef
72.
Zurück zum Zitat Sparkes E, Duarte RV, Mann S, Lawrence TR, Raphael JH (2015) Analysis of psychological characteristics impacting spinal cord stimulation treatment outcomes: a prospective assessment. Pain Physician 18:E369–E377PubMed Sparkes E, Duarte RV, Mann S, Lawrence TR, Raphael JH (2015) Analysis of psychological characteristics impacting spinal cord stimulation treatment outcomes: a prospective assessment. Pain Physician 18:E369–E377PubMed
75.
Zurück zum Zitat Claeys LG, Horsch S (1996) Transcutaneous oxygen pressure as predictive parameter for ulcer healing in endstage vascular patients treated with spinal cord stimulation. Int Angiol 15:344–349PubMed Claeys LG, Horsch S (1996) Transcutaneous oxygen pressure as predictive parameter for ulcer healing in endstage vascular patients treated with spinal cord stimulation. Int Angiol 15:344–349PubMed
76.
Zurück zum Zitat Amann W, Berg P, Gersbach P, Gamain J, Raphael JH, Ubbink DT (2003) Spinal cord stimulation in the treatment of non-reconstructable stable critical leg ischaemia: results of the European Peripheral Vascular Disease Outcome Study (SCS-EPOS). Eur J Vasc Endovasc Surg 26:280–286. doi:10.1053/ejvs.2002.1876 PubMedCrossRef Amann W, Berg P, Gersbach P, Gamain J, Raphael JH, Ubbink DT (2003) Spinal cord stimulation in the treatment of non-reconstructable stable critical leg ischaemia: results of the European Peripheral Vascular Disease Outcome Study (SCS-EPOS). Eur J Vasc Endovasc Surg 26:280–286. doi:10.​1053/​ejvs.​2002.​1876 PubMedCrossRef
77.
Zurück zum Zitat Norrsell H, Eliasson T, Albertsson P, Augustinsson LE, Emanuelsson H, Eriksson P, Mannheimer C (1998) Effects of spinal cord stimulation on coronary blood flow velocity. Coron Artery Dis 9:273–278PubMedCrossRef Norrsell H, Eliasson T, Albertsson P, Augustinsson LE, Emanuelsson H, Eriksson P, Mannheimer C (1998) Effects of spinal cord stimulation on coronary blood flow velocity. Coron Artery Dis 9:273–278PubMedCrossRef
78.
Zurück zum Zitat Kingma JG, Linderoth B, Ardell JL, Armour JA, DeJongste MJ, Foreman RD (2001) Neuromodulation therapy does not influence blood flow distribution or left-ventricular dynamics during acute myocardial ischemia. Auton Neurosci 91:47–54. doi:10.1016/S1566-0702(01)00285-5 PubMedCrossRef Kingma JG, Linderoth B, Ardell JL, Armour JA, DeJongste MJ, Foreman RD (2001) Neuromodulation therapy does not influence blood flow distribution or left-ventricular dynamics during acute myocardial ischemia. Auton Neurosci 91:47–54. doi:10.​1016/​S1566-0702(01)00285-5 PubMedCrossRef
79.
Zurück zum Zitat Hautvast RWM, Blanksma PK, Dejongste MJL, Pruim J, Van Der WE, Vaalburg W, Lie KI (1996) Effect of spinal cord stimulation on myocardial blood flow assessed by positron emission tomography in patients with refractory angina pectoris. Am J Cardiol 77:462–467PubMedCrossRef Hautvast RWM, Blanksma PK, Dejongste MJL, Pruim J, Van Der WE, Vaalburg W, Lie KI (1996) Effect of spinal cord stimulation on myocardial blood flow assessed by positron emission tomography in patients with refractory angina pectoris. Am J Cardiol 77:462–467PubMedCrossRef
80.
Zurück zum Zitat Börjesson M, Andrell P, Lundberg D, Mannheimer C (2008) Spinal cord stimulation in severe angina pectoris—a systematic review based on the Swedish Council on Technology assessment in health care report on long-standing pain. Pain 140:501–508. doi:10.1016/j.pain.2008.10.016 PubMedCrossRef Börjesson M, Andrell P, Lundberg D, Mannheimer C (2008) Spinal cord stimulation in severe angina pectoris—a systematic review based on the Swedish Council on Technology assessment in health care report on long-standing pain. Pain 140:501–508. doi:10.​1016/​j.​pain.​2008.​10.​016 PubMedCrossRef
82.
Zurück zum Zitat Eldabe S, Thomson S, Duarte R, Brookes M, DeBelder M, Raphael J, Davies E, Taylor R (2016) The effectiveness and cost-effectiveness of spinal cord stimulation for refractory angina (RASCAL Study): a pilot randomized controlled trial. Neuromodulation 19:60–70PubMedCrossRef Eldabe S, Thomson S, Duarte R, Brookes M, DeBelder M, Raphael J, Davies E, Taylor R (2016) The effectiveness and cost-effectiveness of spinal cord stimulation for refractory angina (RASCAL Study): a pilot randomized controlled trial. Neuromodulation 19:60–70PubMedCrossRef
86.
Zurück zum Zitat NICE (2011) Deep brain stimulation for refractory chronic pain syndromes (excluding headache). NICE Interv Proced Guid 382:2–7 NICE (2011) Deep brain stimulation for refractory chronic pain syndromes (excluding headache). NICE Interv Proced Guid 382:2–7
89.
91.
Zurück zum Zitat Reinert A, Treede R, Bromm B (2000) The pain inhibiting pain effect: an electrophysiological study in humans. Brain Res 862:103–110PubMedCrossRef Reinert A, Treede R, Bromm B (2000) The pain inhibiting pain effect: an electrophysiological study in humans. Brain Res 862:103–110PubMedCrossRef
92.
Zurück zum Zitat Wand-Tetley JI (1956) Historical methods of counter-irritation. Ann Phys Med 3:90–99PubMed Wand-Tetley JI (1956) Historical methods of counter-irritation. Ann Phys Med 3:90–99PubMed
93.
Zurück zum Zitat Carroll D, Ra M, Hj M, Fairman F, Tramèr M, Leijon G (2000) Transcutaneous electrical nerve stimulation (TENS) for chronic pain (Review). Cochrane Libr 4:1–42 Carroll D, Ra M, Hj M, Fairman F, Tramèr M, Leijon G (2000) Transcutaneous electrical nerve stimulation (TENS) for chronic pain (Review). Cochrane Libr 4:1–42
95.
Zurück zum Zitat Johnson MI (2014) Transcutaneous electrical nerve stimulation (TENS): research to support clinical practice. Oxford University Press, OxfordCrossRef Johnson MI (2014) Transcutaneous electrical nerve stimulation (TENS): research to support clinical practice. Oxford University Press, OxfordCrossRef
96.
Zurück zum Zitat Nash T, Williams J, Machin D (1990) TENS: does the type of stimulus really matter? Pain Clin 3:161–168 Nash T, Williams J, Machin D (1990) TENS: does the type of stimulus really matter? Pain Clin 3:161–168
97.
Zurück zum Zitat McQuay H, Moore R, Eccleston C, Morley S, Williams AC (1997) Systematic review of outpatient services for chronic pain control. Health Technol Assess (Rockv) 1:138 McQuay H, Moore R, Eccleston C, Morley S, Williams AC (1997) Systematic review of outpatient services for chronic pain control. Health Technol Assess (Rockv) 1:138
98.
99.
Zurück zum Zitat Turnbull A (1850) Tincture of capsaicin as a remedy for chilblains and toothache. Dublin Free Press, Dublin, pp 95–96 Turnbull A (1850) Tincture of capsaicin as a remedy for chilblains and toothache. Dublin Free Press, Dublin, pp 95–96
100.
Zurück zum Zitat Szallasi A, Blumberg PM (1999) Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol Rev 51:159–212PubMed Szallasi A, Blumberg PM (1999) Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol Rev 51:159–212PubMed
102.
Zurück zum Zitat Jones VM, Moore KA, Peterson DM (2011) Capsaicin 8% Topical Patch (Qutenza)—a review of the evidence. J Pain Palliat Care Pharmacother Jones VM, Moore KA, Peterson DM (2011) Capsaicin 8% Topical Patch (Qutenza)—a review of the evidence. J Pain Palliat Care Pharmacother
103.
Zurück zum Zitat Maihofner C, Heskamp M-L (2013) Prospective, non-interventional study on the tolerability and analgesic effectiveness over 12 weeks after a single application of capsaicin 8% cutaneous patch in 1044 patients with peripheral neuropathic pain: first results of the QUEPP study. Curr Med Res Opin 29:673–683. doi:10.1185/03007995.2013.792246 PubMedCrossRef Maihofner C, Heskamp M-L (2013) Prospective, non-interventional study on the tolerability and analgesic effectiveness over 12 weeks after a single application of capsaicin 8% cutaneous patch in 1044 patients with peripheral neuropathic pain: first results of the QUEPP study. Curr Med Res Opin 29:673–683. doi:10.​1185/​03007995.​2013.​792246 PubMedCrossRef
104.
Zurück zum Zitat Health and Social Care Information Centre (2014) Prescription cost analysis—England 2013. HSCIC 677 Health and Social Care Information Centre (2014) Prescription cost analysis—England 2013. HSCIC 677
105.
Zurück zum Zitat Oosterveld FG, Rasker JJ (1994) Treating arthritis with locally applied heat or cold. Semin Arthritis Rheum 24:82–90PubMedCrossRef Oosterveld FG, Rasker JJ (1994) Treating arthritis with locally applied heat or cold. Semin Arthritis Rheum 24:82–90PubMedCrossRef
106.
Zurück zum Zitat Brosseau L, Yonge K a, Robinson V, Marchand S, Judd M, Wells G, Tugwell P (2003) Thermotherapy for treatment of osteoarthritis. Cochrane Database Syst Rev CD004522. doi:10.1016/S0031-9406(05)60490-7 Brosseau L, Yonge K a, Robinson V, Marchand S, Judd M, Wells G, Tugwell P (2003) Thermotherapy for treatment of osteoarthritis. Cochrane Database Syst Rev CD004522. doi:10.​1016/​S0031-9406(05)60490-7
108.
Zurück zum Zitat Lehmann JF, Warren CG, Scham SM (1974) Therapeutic heat and cold. Clin Orthop Relat Res 99:207–245CrossRef Lehmann JF, Warren CG, Scham SM (1974) Therapeutic heat and cold. Clin Orthop Relat Res 99:207–245CrossRef
109.
Zurück zum Zitat Le Bars D, Dickenson AH, Besson JM (1979) Diffuse noxious inhibitory controls (DNIC). I. Effects on dorsal horn convergent neurones in the rat. Pain 6:283–304PubMedCrossRef Le Bars D, Dickenson AH, Besson JM (1979) Diffuse noxious inhibitory controls (DNIC). I. Effects on dorsal horn convergent neurones in the rat. Pain 6:283–304PubMedCrossRef
111.
Zurück zum Zitat Melzack R (1999) From the gate to the neuromatrix. Pain 82:S121–S126CrossRef Melzack R (1999) From the gate to the neuromatrix. Pain 82:S121–S126CrossRef
112.
Zurück zum Zitat Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D (2006) Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain 10:287–333PubMedCrossRef Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D (2006) Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain 10:287–333PubMedCrossRef
113.
Zurück zum Zitat Price C, Hoggart B, Olukoga O, Williams ACDC, Bottle A (2012) National Pain Audit Final Report 2010–2012 Price C, Hoggart B, Olukoga O, Williams ACDC, Bottle A (2012) National Pain Audit Final Report 2010–2012
114.
Zurück zum Zitat Sabers S (2003) The role of physical therapy in chronic pain. In: Rice A, Warfield C, Justins D, Eccleston C (eds) Clin. Pain Manag. Chronic Pain. Arnold, London, pp 313–324 Sabers S (2003) The role of physical therapy in chronic pain. In: Rice A, Warfield C, Justins D, Eccleston C (eds) Clin. Pain Manag. Chronic Pain. Arnold, London, pp 313–324
115.
Zurück zum Zitat Hayden J, Van Tulder M, Malmivaara A, Koes B (2005) Exercise therapy for treatment of non-specific low back pain. Cochrane Database Syst Rev 2:1–83 Hayden J, Van Tulder M, Malmivaara A, Koes B (2005) Exercise therapy for treatment of non-specific low back pain. Cochrane Database Syst Rev 2:1–83
116.
Zurück zum Zitat Engel J (2013) Evaluation and pain management. In: Pendleton H, Schultz-Krohn W (eds) Pendretti’s Occup. Ther, 7th edn. Elsevier, Mosby, p 1328 Engel J (2013) Evaluation and pain management. In: Pendleton H, Schultz-Krohn W (eds) Pendretti’s Occup. Ther, 7th edn. Elsevier, Mosby, p 1328
118.
Zurück zum Zitat Turk DC, Monarch E (2002) Biopsychosocial perspective on chronic pain. In: Turk D, Gatchel RJ (eds) Psychological approaches to pain management, 2nd edn. Guilford Press, New York, NY, p 590 Turk DC, Monarch E (2002) Biopsychosocial perspective on chronic pain. In: Turk D, Gatchel RJ (eds) Psychological approaches to pain management, 2nd edn. Guilford Press, New York, NY, p 590
119.
Zurück zum Zitat Williams S (2013) Pain Management Programmes 2013 National Directory of Services Williams S (2013) Pain Management Programmes 2013 National Directory of Services
120.
Zurück zum Zitat Jeffery MM, Butler M, Stark A, Kane RL (2011) Multidisciplinary pain programs for chronic noncancer pain. Agency for Healthcare Research and Quality (US), Rockville Jeffery MM, Butler M, Stark A, Kane RL (2011) Multidisciplinary pain programs for chronic noncancer pain. Agency for Healthcare Research and Quality (US), Rockville
121.
Zurück zum Zitat Loeser JD, Turk DC (2001) Multidisciplinary pain management. In: Loeser JD (ed) Bonica’s Management Pain, 3rd edn. Lippincott, Williams & Wilkins, Philadelphia, pp 2069–2079 Loeser JD, Turk DC (2001) Multidisciplinary pain management. In: Loeser JD (ed) Bonica’s Management Pain, 3rd edn. Lippincott, Williams & Wilkins, Philadelphia, pp 2069–2079
122.
Zurück zum Zitat British Pain Society (2013) The British Pain Society Guidelines for Pain Management Programmes for adults British Pain Society (2013) The British Pain Society Guidelines for Pain Management Programmes for adults
123.
Zurück zum Zitat Beck A, Rush A, Shaw B, Emery G (1979) Cognitive therapy of depression. Guilford Press, New York Beck A, Rush A, Shaw B, Emery G (1979) Cognitive therapy of depression. Guilford Press, New York
125.
Zurück zum Zitat Turk D, Meichenbaum D, Genest M (1983) Pain and behavioral medicine: a cognitive–behavioral perspective. Guilford Press, New York Turk D, Meichenbaum D, Genest M (1983) Pain and behavioral medicine: a cognitive–behavioral perspective. Guilford Press, New York
126.
Zurück zum Zitat Bogaards MC, ter Kuile MM (1994) Treatment of recurrent tension headache: a meta-analytic review. Clin J Pain 10:174–190PubMedCrossRef Bogaards MC, ter Kuile MM (1994) Treatment of recurrent tension headache: a meta-analytic review. Clin J Pain 10:174–190PubMedCrossRef
127.
Zurück zum Zitat Morley S, Eccleston C, Williams A (1999) Systematic review and meta-analysis of randomized controlled trials of cognitive behaviour therapy and behaviour therapy for chronic pain in adults, excluding headache. Pain 80:1–13PubMedCrossRef Morley S, Eccleston C, Williams A (1999) Systematic review and meta-analysis of randomized controlled trials of cognitive behaviour therapy and behaviour therapy for chronic pain in adults, excluding headache. Pain 80:1–13PubMedCrossRef
129.
Zurück zum Zitat Henschke N, Ostelo R, Van Tulder M, Vlaeyen J, Morley S, Assendelft W, Main C (2010) Behavioural treatment for chronic low-back pain (Review). Cochrane Database Syst Rev 7:1–124 Henschke N, Ostelo R, Van Tulder M, Vlaeyen J, Morley S, Assendelft W, Main C (2010) Behavioural treatment for chronic low-back pain (Review). Cochrane Database Syst Rev 7:1–124
130.
Zurück zum Zitat Williams ACDC, Eccleston C, Morley S (2012) Psychological therapies for the management of chronic pain (excluding headache) in adults (Review). Cochrane Libr 11:1–107 Williams ACDC, Eccleston C, Morley S (2012) Psychological therapies for the management of chronic pain (excluding headache) in adults (Review). Cochrane Libr 11:1–107
131.
Zurück zum Zitat Moore RK, Groves D, Bateson S, Barlow P, Hammond C, Leach AA, Chester MR (2005) Health related quality of life of patients with refractory angina before and one year after enrolment onto a refractory angina program. Eur J Pain 9:305–310. doi:10.1016/j.ejpain.2004.07.013 PubMedCrossRef Moore RK, Groves D, Bateson S, Barlow P, Hammond C, Leach AA, Chester MR (2005) Health related quality of life of patients with refractory angina before and one year after enrolment onto a refractory angina program. Eur J Pain 9:305–310. doi:10.​1016/​j.​ejpain.​2004.​07.​013 PubMedCrossRef
132.
133.
Zurück zum Zitat Hayes SC, Strosahl KD, Wilson KG (1999) Acceptance and commitment therapy: an experiential approach to behavior change. Guilford Press, New York Hayes SC, Strosahl KD, Wilson KG (1999) Acceptance and commitment therapy: an experiential approach to behavior change. Guilford Press, New York
135.
Zurück zum Zitat Hayes S (2004) Acceptance and commitment therapy and the new behaviour therapies. In: Hayes SC, Follette V, Linehan M (eds) Mindfulness and acceptance: expanding the cognitive–behavioral tradition. Guilford Press, New York, pp 1–29 Hayes S (2004) Acceptance and commitment therapy and the new behaviour therapies. In: Hayes SC, Follette V, Linehan M (eds) Mindfulness and acceptance: expanding the cognitive–behavioral tradition. Guilford Press, New York, pp 1–29
139.
Zurück zum Zitat Kabat-Zinn J (1994) Wherever you go, there you are: mindfulness meditation in everyday life. Hyperion, New York Kabat-Zinn J (1994) Wherever you go, there you are: mindfulness meditation in everyday life. Hyperion, New York
141.
Zurück zum Zitat Hann KEJ, McCracken LM (2014) A systematic review of randomized controlled trials of Acceptance and Commitment Therapy for adults with chronic pain: outcome domains, design quality, and efficacy. J Context Behav Sci 3:1–39. doi:10.1016/j.jcbs.2014.10.001 CrossRef Hann KEJ, McCracken LM (2014) A systematic review of randomized controlled trials of Acceptance and Commitment Therapy for adults with chronic pain: outcome domains, design quality, and efficacy. J Context Behav Sci 3:1–39. doi:10.​1016/​j.​jcbs.​2014.​10.​001 CrossRef
Metadaten
Titel
An overview of treatment approaches for chronic pain management
verfasst von
Nicholas Hylands-White
Rui V. Duarte
Jon H. Raphael
Publikationsdatum
23.04.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Rheumatology International / Ausgabe 1/2017
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-016-3481-8

Weitere Artikel der Ausgabe 1/2017

Rheumatology International 1/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.